333 related articles for article (PubMed ID: 30596206)
1. New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders.
Ferré S; Díaz-Ríos M; Salamone JD; Prediger RD
J Caffeine Adenosine Res; 2018 Dec; 8(4):121-131. PubMed ID: 30596206
[TBL] [Abstract][Full Text] [Related]
2. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A
Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D
Front Pharmacol; 2018; 9():243. PubMed ID: 29686613
[TBL] [Abstract][Full Text] [Related]
3. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
4. Functional and Neuroprotective Role of Striatal Adenosine A
Ferré S; Ciruela F
J Caffeine Adenosine Res; 2019 Sep; 9(3):89-97. PubMed ID: 31559390
[TBL] [Abstract][Full Text] [Related]
5. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.
Casadó-Anguera V; Bonaventura J; Moreno E; Navarro G; Cortés A; Ferré S; Casadó V
Biochem Soc Trans; 2016 Apr; 44(2):595-600. PubMed ID: 27068975
[TBL] [Abstract][Full Text] [Related]
7. Allosteric Interactions between Adenosine A
Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
[TBL] [Abstract][Full Text] [Related]
8. Control of glutamate release by complexes of adenosine and cannabinoid receptors.
Köfalvi A; Moreno E; Cordomí A; Cai NS; Fernández-Dueñas V; Ferreira SG; Guixà-González R; Sánchez-Soto M; Yano H; Casadó-Anguera V; Cunha RA; Sebastião AM; Ciruela F; Pardo L; Casadó V; Ferré S
BMC Biol; 2020 Jan; 18(1):9. PubMed ID: 31973708
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum.
Ferré S; Sarasola LI; Quiroz C; Ciruela F
Neuropharmacology; 2023 Feb; 223():109329. PubMed ID: 36375695
[TBL] [Abstract][Full Text] [Related]
10. The heterotetrameric structure of the adenosine A
Cortés A; Casadó-Anguera V; Moreno E; Casadó V
Adv Pharmacol; 2019; 84():37-78. PubMed ID: 31229177
[TBL] [Abstract][Full Text] [Related]
11. Cross-communication between G
Navarro G; Cordomí A; Brugarolas M; Moreno E; Aguinaga D; Pérez-Benito L; Ferre S; Cortés A; Casadó V; Mallol J; Canela EI; Lluís C; Pardo L; McCormick PJ; Franco R
BMC Biol; 2018 Feb; 16(1):24. PubMed ID: 29486745
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.
Ciruela F; Casadó V; Rodrigues RJ; Luján R; Burgueño J; Canals M; Borycz J; Rebola N; Goldberg SR; Mallol J; Cortés A; Canela EI; López-Giménez JF; Milligan G; Lluis C; Cunha RA; Ferré S; Franco R
J Neurosci; 2006 Feb; 26(7):2080-7. PubMed ID: 16481441
[TBL] [Abstract][Full Text] [Related]
13. Mapping the Interface of a GPCR Dimer: A Structural Model of the A
Borroto-Escuela DO; Rodriguez D; Romero-Fernandez W; Kapla J; Jaiteh M; Ranganathan A; Lazarova T; Fuxe K; Carlsson J
Front Pharmacol; 2018; 9():829. PubMed ID: 30214407
[TBL] [Abstract][Full Text] [Related]
14. Decreased striatal adenosine A
Valle-León M; Callado LF; Aso E; Cajiao-Manrique MM; Sahlholm K; López-Cano M; Soler C; Altafaj X; Watanabe M; Ferré S; Fernández-Dueñas V; Menchón JM; Ciruela F
Neuropsychopharmacology; 2021 Feb; 46(3):665-672. PubMed ID: 33010795
[TBL] [Abstract][Full Text] [Related]
15. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
Fuxe K; Guidolin D; Agnati LF; Borroto-Escuela DO
Expert Opin Ther Targets; 2015 Mar; 19(3):377-98. PubMed ID: 25486101
[TBL] [Abstract][Full Text] [Related]
16. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A
Sarasola LI; Del Torrent CL; Pérez-Arévalo A; Argerich J; Casajuana-Martín N; Chevigné A; Fernández-Dueñas V; Ferré S; Pardo L; Ciruela F
Biomed Pharmacother; 2022 Dec; 156():113896. PubMed ID: 36279718
[TBL] [Abstract][Full Text] [Related]
17. Revealing Adenosine A
Fernández-Dueñas V; Gómez-Soler M; Valle-León M; Watanabe M; Ferrer I; Ciruela F
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340557
[No Abstract] [Full Text] [Related]
18. Pharmacological targeting of G protein-coupled receptor heteromers.
Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
[TBL] [Abstract][Full Text] [Related]
19. Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.
Borroto-Escuela DO; Fuxe K
J Neural Transm (Vienna); 2019 Apr; 126(4):455-471. PubMed ID: 30637481
[TBL] [Abstract][Full Text] [Related]
20. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
Halldner L; Adén U; Dahlberg V; Johansson B; Ledent C; Fredholm BB
Neuropharmacology; 2004 Jun; 46(7):1008-17. PubMed ID: 15081797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
